To view this email as a web page, click here.

 
Immunity persists for at least 3 years after receipt of new shingles vaccine
Immune responses to the latest shingles vaccine (Shingrix) last for at least three years following vaccination. The robust immune responses develop and persist in all age groups, according to a recent study in The Journal of Infectious Diseases.
ADVERTISEMENT
 
Fine tuning dosing schedules of targeted agents may improve responses in melanoma
Changing the schedule of targeted therapies has been shown to improve the response rate in a mouse model of melanoma.
ADVERTISEMENT
 
Biosimilars safety performance in psoriasis
A study that compares the safety, efficacy and drug survival of biologics to biosimilars, finds that switching to a biosimilar had no significant impact on drug survival or safe.
ADVERTISEMENT
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
The best minds on rosacea, all in one place
Articles, commentary, data and more from Dermatology Times. Explore it now!
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.